Characterization of an Infectious Cdna Copy of the Genome of a Naturally Occurring, Avirulent Coxsackievirus B3 Clinical Isolate

Group B coxsackieviruses (CVB) cause numerous diseases, including myocarditis, pancreatitis, aseptic meningitis and possibly type 1 diabetes. To date, infectious cDNA copies of CVB type 3 (CVB3) genomes have all been derived from pathogenic virus strains. An infectious cDNA copy of the well-characterized, non-pathogenic CVB3 strain GA genome was cloned in order to facilitate mapping of the CVB genes that influence expression of a virulence phenotype. Comparison of the sequence of the parental CVB3/GA population, derived by direct RT-PCR-mediated sequence analysis, to that of the infectious CVB3/GA progeny genome demonstrated that an authentic copy was cloned; numerous differences were observed in coding and non-coding sequences relative to other CVB3 strains. Progeny CVB3/GA replicated similarly to the parental strain in three different cell cultures and was avirulent when inoculated into mice, causing neither pancreatitis nor myocarditis. Inoculation of mice with CVB3/GA protected mice completely against myocarditis and pancreatitis induced by cardiovirulent CVB3 challenge. The secondary structure predicted for the CVB3/GA domain II, a region within the 59 non-translated region that is implicated as a key site affecting the expression of a cardiovirulent phenotype, differs from those predicted for cardiovirulent and pancreovirulent CVB3 strains. This is the first report characterizing a cloned CVB3 genome from an avirulent strain. INTRODUCTION Group B coxsackieviruses (CVB1–6) are enteroviruses in the species Human enterovirus B (HEV-B), family Picorna-viridae (Pallansch & Roos, 2001). The CVB genome comprises a positive-stranded RNA that is 7400 nt long; the single ORF encodes a 2200 aa polyprotein that is processed during translation by two viral proteases. The ORF is flanked by 59 and 39 non-translated regions (NTRs), which encode no proteins, but are highly structured RNA sequences that are important for virus replication (Jackson & Kaminski, 1995; Liu et al., 1999). CVB cause diverse human diseases, including myocarditis, pancreatitis, aseptic meningitis and possibly type 1 diabetes (Bowles et al. CVB3 strains can be myocarditic (inducing both myo-carditis and pancreatitis in mice) or pancreovirulent (inducing only pancreatitis) (Tracy et al., 2000). Assays of diverse CVB3 strains in mice, isolated between the early 3These authors contributed equally to this work. 1950s and the late 1990s, suggest that avirulent strains are rare (Tracy et al., 2000; S. Tracy, unpublished data). It is unknown whether this is due to a sampling bias, as most CVB strains are isolated from suspected cases of viral disease and thus would be expected to express a virulent phenotype, or …

[1]  S. Tracy,et al.  Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection. , 2004, Virology.

[2]  W. Melchers,et al.  Mutational Analysis of Different Regions in the Coxsackievirus 2B Protein , 2004, Journal of Biological Chemistry.

[3]  B. Semler,et al.  Strand-Specific RNA Synthesis Determinants in the RNA-Dependent RNA Polymerase of Poliovirus , 2004, Journal of Virology.

[4]  P. E. Tam,et al.  Multiple Viral Determinants Mediate Myopathogenicity in Coxsackievirus B1-Induced Chronic Inflammatory Myopathy , 2003, Journal of Virology.

[5]  D. Wuttke,et al.  Towards an understanding of the poliovirus replication complex: the solution structure of the soluble domain of the poliovirus 3A protein. , 2003, Journal of molecular biology.

[6]  Michael Zuker,et al.  Mfold web server for nucleic acid folding and hybridization prediction , 2003, Nucleic Acids Res..

[7]  N. Chapman,et al.  The stem loop II within the 5' nontranslated region of clinical coxsackievirus B3 genomes determines cardiovirulence phenotype in a murine model. , 2003, The Journal of infectious diseases.

[8]  A. Bruu Enteroviruses: Polioviruses, Coxsackieviruses, Echoviruses and Newer Enteroviruses , 2003 .

[9]  P. Minor Polio vaccines and the cessation of vaccination , 2003, Expert review of vaccines.

[10]  B. McManus,et al.  A shine-dalgarno-like sequence mediates in vitro ribosomal internal entry and subsequent scanning for translation initiation of coxsackievirus B3 RNA. , 2003, Virology.

[11]  N. Chapman,et al.  Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence , 2002, Journal of Virology.

[12]  J. Galama,et al.  Biological Significance of a Human Enterovirus B-Specific RNA Element in the 3′ Nontranslated Region , 2002, Journal of Virology.

[13]  T. Kanno,et al.  Virulence of swine vesicular disease virus is determined at two amino acids in capsid protein VP1 and 2A protease. , 2001, Virus research.

[14]  Michael G. Rossmann,et al.  Interaction of coxsackievirus B3 with the full length coxsackievirus-adenovirus receptor , 2001, Nature Structural Biology.

[15]  R. Zell,et al.  Expression of Immunoregulatory Cytokines by Recombinant Coxsackievirus B3 Variants Confers Protection against Virus-Caused Myocarditis , 2001, Journal of Virology.

[16]  Shelton S. Bradrick,et al.  A Predicted Secondary Structural Domain within the Internal Ribosome Entry Site of Echovirus 12 Mediates a Cell-Type-Specific Block to Viral Replication , 2001, Journal of Virology.

[17]  E. Wimmer,et al.  The C-terminal residues of poliovirus proteinase 2A(pro) are critical for viral RNA replication but not for cis- or trans-proteolytic cleavage. , 2001, The Journal of general virology.

[18]  N. Chapman,et al.  Coxsackievirus Expression of the Murine Secretory Protein Interleukin-4 Induces Increased Synthesis of Immunoglobulin G1 in Mice , 2000, Journal of Virology.

[19]  K. Höfling,et al.  Group B coxsackievirus myocarditis and pancreatitis: Connection between viral virulence phenotypes in mice , 2000, Journal of medical virology.

[20]  N. Chapman,et al.  Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5′ Nontranslated Region , 2000, Journal of virology.

[21]  J. Meredith,et al.  Identification of a cis-Acting Replication Element within the Poliovirus Coding Region , 2000, Journal of Virology.

[22]  N. Chapman,et al.  Expression of an Antigenic Adenovirus Epitope in a Group B Coxsackievirus , 2000, Journal of Virology.

[23]  B. Semler,et al.  A Group B Coxsackievirus/Poliovirus 5′ Nontranslated Region Chimera Can Act as an Attenuated Vaccine Strain in Mice , 2000, Journal of Virology.

[24]  A. Ramsingh,et al.  A point mutation in VP1 of coxsackievirus B4 alters antigenicity. , 2000, Virology.

[25]  R. Andino,et al.  Interactions of Viral Protein 3CD and Poly(rC) Binding Protein with the 5′ Untranslated Region of the Poliovirus Genome , 2000, Journal of Virology.

[26]  B. McManus,et al.  Structural and functional analysis of the 5' untranslated region of coxsackievirus B3 RNA: In vivo translational and infectivity studies of full-length mutants. , 1999, Virology.

[27]  S. Martin,et al.  Functional features of the bovine enterovirus 5'-non-translated region. , 1999, The Journal of general virology.

[28]  S. Yamaguchi,et al.  Mapping the Genetic Determinants of Pathogenicity and Plaque Phenotype in Swine Vesicular Disease Virus , 1999, Journal of Virology.

[29]  G. Clements,et al.  Simultaneous onset of Type 1 diabetes mellitus in identical infant twins with enterovirus infection , 1998, Diabetic medicine : a journal of the British Diabetic Association.

[30]  H. Hyöty,et al.  Enterovirus infections and insulin dependent diabetes mellitus--evidence for causality. , 1998, Clinical and diagnostic virology.

[31]  A. Ramsingh Coxsackieviruses and pancreatitis. , 1997, Frontiers in bioscience : a journal and virtual library.

[32]  J. Hansen,et al.  Structure of the RNA-dependent RNA polymerase of poliovirus. , 1997, Structure.

[33]  N. Chapman,et al.  Generation of an infectious cDNA of a highly cardiovirulent coxsackievirus B3(CVB3m) and comparison to other infectious CVB3 cDNAs. , 1997, Virus research.

[34]  B. Semler,et al.  Requirement of poly(rC) binding protein 2 for translation of poliovirus RNA , 1997, Journal of virology.

[35]  S. Huber Autoimmunity in myocarditis: relevance of animal models. , 1997, Clinical immunology and immunopathology.

[36]  R. Wessely,et al.  A mutation in the puff region of VP2 attenuates the myocarditic phenotype of an infectious cDNA of the Woodruff variant of coxsackievirus B3 , 1996, Journal of virology.

[37]  B. Semler,et al.  Determinants of Membrane Association for Poliovirus Protein 3AB* , 1996, The Journal of Biological Chemistry.

[38]  R. Jackson,et al.  Internal initiation of translation in eukaryotes: the picornavirus paradigm and beyond. , 1995, RNA.

[39]  D. N. Collins,et al.  A point mutation in the VP4 coding sequence of coxsackievirus B4 influences virulence , 1995, Journal of virology.

[40]  P. Hofschneider,et al.  Characterization of a 100-kilodalton binding protein for the six serotypes of coxsackie B viruses , 1995, Journal of virology.

[41]  K. Currey,et al.  The cardiovirulent phenotype of coxsackievirus B3 is determined at a single site in the genomic 5' nontranslated region , 1995, Journal of virology.

[42]  M G Rossmann,et al.  The structure of coxsackievirus B3 at 3.5 A resolution. , 1995, Structure.

[43]  B. Strauer,et al.  Identification of serotype-specific and nonserotype-specific B-cell epitopes of coxsackie B virus using synthetic peptides. , 1994, Virology.

[44]  P. Auvinen,et al.  Mapping of antigenic sites of coxsackievirus B3 by synthetic peptides , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.

[45]  R. Brookmeyer,et al.  The evolution of virus diseases: their emergence, epidemicity, and control. , 1993, Virus research.

[46]  J. McCauley,et al.  Complete nucleotide sequence of a coxsackie B5 virus and its relationship to swine vesicular disease virus. , 1993, The Journal of general virology.

[47]  S. Le,et al.  Conserved tertiary structure elements in the 5′ untranslated region of human enteroviruses and rhinoviruses , 1992, Virology.

[48]  P. Minor The molecular biology of poliovaccines. , 1992, The Journal of general virology.

[49]  D. Stone,et al.  Correlation of RNA secondary structure and attenuation of Sabin vaccine strains of poliovirus in tissue culture. , 1992, Virology.

[50]  R. Gómez,et al.  Murine acinar pancreatitis preceding necrotizing myocarditis after coxsackievirus B3 inoculation , 1991, Journal of medical virology.

[51]  H. Yonekawa,et al.  Nucleotide sequences important for translation initiation of enterovirus RNA , 1991, Journal of virology.

[52]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.

[53]  M. Pallansch,et al.  Echovirus 22 is an atypical enterovirus , 1990, Journal of virology.

[54]  A. Ramsingh,et al.  Evidence suggesting that virulence maps to the P1 region of the coxsackievirus B4 genome , 1990, Journal of virology.

[55]  A. Nomoto,et al.  Determinants in the 5' noncoding region of poliovirus Sabin 1 RNA that influence the attenuation phenotype , 1989, Journal of virology.

[56]  A. Nomoto,et al.  A recombinant virus between the Sabin 1 and Sabin 3 vaccine strains of poliovirus as a possible candidate for a new type 3 poliovirus live vaccine strain , 1988, Journal of virology.

[57]  D. Filman,et al.  Three-dimensional structure of poliovirus serotype 1 neutralizing determinants , 1988, Journal of virology.

[58]  J. Icenogle,et al.  Antigenic structure of polioviruses of serotypes 1, 2 and 3. , 1986, The Journal of general virology.

[59]  N. Bowles,et al.  DETECTION OF COXSACKIE-B-VIRUS-SPECIFIC RNA SEQUENCES IN MYOCARDIAL BIOPSY SAMPLES FROM PATIENTS WITH MYOCARDITIS AND DILATED CARDIOMYOPATHY , 1986, The Lancet.

[60]  I. Talbot,et al.  Severe Pancreatitis and Fatty Liver Progressing to Cirrhosis Associated with Coxsackie B4 Infection in a Three Year Old with Alpha‐1‐Antitrypsin Deficiency , 1986, Acta paediatrica Scandinavica.

[61]  B. Sherry,et al.  Use of monoclonal antibodies to identify four neutralization immunogens on a common cold picornavirus, human rhinovirus 14 , 1986, Journal of virology.

[62]  P. Hofschneider,et al.  Molecular cloning of the genome of a cardiotropic Coxsackie B3 virus: full-length reverse-transcribed recombinant cDNA generates infectious virus in mammalian cells. , 1985, Proceedings of the National Academy of Sciences of the United States of America.

[63]  J. Maizel,et al.  Increased neurovirulence associated with a single nucleotide change in a noncoding region of the Sabin type 3 poliovaccine genome , 1985, Nature.

[64]  B. Sherry,et al.  Evidence for at least two dominant neutralization antigens on human rhinovirus 14 , 1985, Journal of virology.

[65]  M. Kaplan,et al.  Group B coxsackievirus infections in infants younger than three months of age: a serious childhood illness. , 1983, Reviews of infectious diseases.

[66]  T. Mertens,et al.  Neutralizing antibodies against Coxsackie B viruses in patients with recent onset of type I diabetes , 1983, European Journal of Pediatrics.

[67]  C. Gauntt,et al.  Temperature-Sensitive Mutant of Coxsackievirus B3 Establishes Resistance in Neonatal Mice That Protects Them During Adolescence Against Coxsackievirus B3-Induced Myocarditis , 1983, Infection and immunity.

[68]  N. Nathanson,et al.  The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. , 1979, American journal of epidemiology.

[69]  J. C. Ferguson,et al.  Coxsackie and mumpsvirus infection in a prospective study of acute pancreatitis. , 1977, Gut.

[70]  F. Brown,et al.  Antigenic Differences between Isolates of Swine Vesicular Disease Virus and their Relationship to Coxsackie B5 Virus , 1973, Nature.

[71]  B. Ursing Acute pancreatitis in coxsackie B infection. , 1973, British medical journal.

[72]  F. Cole,et al.  Isolation of a Coxsackie virus group B, type 5, from the heart of a fatal case of myocarditis in an adult , 1969, Journal of clinical pathology.

[73]  K. Benirschke,et al.  Severe generalized disease (encephalohepatomyocarditis) occurring in the newborn period and due to infection with Coxsackie virus, group B; evidence of intrauterine infection with this agent. , 1958, Pediatrics.

[74]  A. Sabin CHARACTERISTICS AND GENETIC POTENTIALITIES OF EXPERIMENTALLY PRODUCED AND NATURALLY OCCURRING VARIANTS OF POLIOMYELITIS VIRUS , 1955, Annals of the New York Academy of Sciences.

[75]  M. Disney,et al.  Bornholm Disease in Children , 1953, British medical journal.

[76]  E. W. Shaw,et al.  A Virus Isolated from Patients Diagnosed as Non-Paralytic Poliomyelitis or Aseptic Meningitis.∗ , 1949, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[77]  N. Chapman,et al.  Coxsackievirus B3 from an infectious cDNA copy of the genome is cardiovirulent in mice , 2005, Archives of Virology.

[78]  N. Chapman,et al.  An infectious cDNA copy of the genome of a non-cardiovirulent coxsackievirus B3 strain: its complete sequence analysis and comparison to the genomes of cardiovirulent coxsackieviruses , 2005, Archives of Virology.

[79]  D. Kerrigan,et al.  Structure and function analysis of the poliovirus cis-acting replication element (CRE). , 2003, RNA.

[80]  K. Currey,et al.  Mutations in a conserved enteroviral RNA oligonucleotide sequence affect positive strand viral RNA synthesis , 2000, Archives of Virology.

[81]  J. McCauley,et al.  Coxsackievirus B5 and the relationship to swine vesicular disease virus. , 1997, Current topics in microbiology and immunology.

[82]  J. Romero,et al.  Genetic divergence among the group B coxsackieviruses. , 1997, Current topics in microbiology and immunology.

[83]  R. Ren,et al.  Poliovirus biology and pathogenesis. , 1996, Current topics in microbiology and immunology.

[84]  T. Martino,et al.  Enteroviral Myocarditis and Dilated Cardiomyopathy: a Review of Clinical and Experimental Studies , 1995 .

[85]  A. Moraska,et al.  T lymphocyte responses in CVB3-induced murine myocarditis. , 1993, Scandinavian journal of infectious diseases. Supplementum.

[86]  S. R. Pollard,et al.  Genetic basis of attenuation of the Sabin type 2 vaccine strain of poliovirus in primates. , 1993, Virology.

[87]  S. Baekkeskov,et al.  The 64-kDa beta cell membrane autoantigen and other target molecules of humoral autoimmunity in insulin-dependent diabetes mellitus. , 1990, Current topics in microbiology and immunology.

[88]  V. Racaniello Poliovirus neurovirulence. , 1988, Advances in Virus Research.

[89]  E. Nordenfelt,et al.  Enterovirus infections in acute pancreatitis - a possible etiological connection. , 1976, Scandinavian journal of gastroenterology.

[90]  A. Sabin,et al.  History of Sabin attenuated poliovirus oral live vaccine strains , 1973 .

[91]  S. V. van Creveld,et al.  Myocarditis in newborns, caused by coxsackie virus; clinical and pathological data. , 1956, Annales paediatrici. International review of pediatrics.

[92]  G. Dalldorf The Coxsackie viruses. , 1951, Postgraduate medicine.